Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,587.52
(
0.32%
)
US TECH 100
29,540.40
(
0.40%
)
Dow Jones
51,071.40
(
0.79%
)
Brent Oil
90.59
(
-1.73%
)
Bitcoin
73,855.72
(
0.43%
)
News Focus
News Focus

Replies to post #149834 on Elite Pharmaceuticals Inc (ELTP)

Replies to #149834 on Elite Pharmaceuticals Inc (ELTP)
icon url

WeeZuhl

04/02/15 11:19 PM

#149835 RE: dr_lowenstein #149834

You may be right, doc...

So you agree, then, that ELI-200 is an abuse-deterrent immediate-release oxycodone product. What do you think of the potential of such a product?
icon url

WeeZuhl

04/02/15 11:41 PM

#149836 RE: dr_lowenstein #149834

Immediate release is just that. No polymers or coatings that delay the release. Common terms would be delayed, or controlled or extended release











Seems to me that some hypothetical company, perhaps a company that "specializes in oral sustained and controlled release drug products" just might be able to create a single agonist bead that mimics the plasma concentration characteristics of both an IR and ER product. One could theoretically, albeit in-artfully, refer to such a product as intermediate release.